Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease

被引:37
|
作者
Vizzutti, Francesco
Arena, Umberto
Rega, Luigi
Romanelli, Roberto Giulio
Colagrande, Stefano
Cuofano, Stefania
Moscarella, Stefania
Belli, Giacomo
Marra, Fabio
Laffi, Giacomo
Pinzani, Massimo
机构
[1] Univ Florence, Dipartimento Med Interna, I-50134 Florence, Italy
[2] Dipartimento Fisiopatol Clin Sez Radiodiagnost, Florence, Italy
[3] Azienda Osped Univ Careggi, SOD Fis Sanitaria, Florence, Italy
[4] Univ Florence, Ctr Res Higher Educ & Transfer DENOThe, Florence, Italy
关键词
doppler ultrasonography; liver cirrhosis portal; hypertension;
D O I
10.1111/j.1478-3231.2007.01563.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose: To evaluate the correlation between hepatic vein pressure gradient measurement and Doppler ultrasonography (DUS) in patients with chronic liver disease (CLD). Patients and methods: Sixty-six patients with fibrotic to cirrhotic hepatitis C virus-related CLD, were consecutively included upon referral to our haemodynamic laboratory. Superior mesenteric artery pulsatility index (SMA-PI), right interlobar renal and intraparenchymal splenic artery resistance indices, were determined, followed by hepatic venous pressure gradient (HVPG) measurement. Results: A correlation was found between HVPG and intraparenchymal splenic artery resistance index (SA-RI) (r=0.50, P < 0.0001), SMA-PI (r=-0,48, P < 0.0001), right interlobar renal artery resistance index (RRA-RI) (r=0.51, P < 0.0001) in the whole patient population. However, dividing patients according to the presence/absence of severe portal hypertension (i.e. HVPG >= 12 mmHg), a correlation between HVPG and intraparenchymal SA-RI (r=0.70, P < 0.0001), SMA-PI (r=-0.49, P=0.02), RRA-RI (r=0.66, P=0.0002) was observed only for HVPG values < 12 mmHg. HVPG but not DUS correlated with the presence of esophageal varices (P < 0.0001). Conclusions: Superior mesenteric artery pulsatility index, intraparenchymal splenic and right interlobar renal artery resistance indices do not adequately predict severe portal hypertension.
引用
收藏
页码:1379 / 1388
页数:10
相关论文
共 50 条
  • [1] Autoantibodies in Hepatitis C Virus-Related Chronic Liver Disease
    Himoto, Takashi
    Nishioka, Mikio
    [J]. HEPATITIS MONTHLY, 2008, 8 (04) : 295 - 303
  • [2] Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease
    Jean-Claude Trinchet
    Nathalie Ganne-Carrié
    Pierre Nahon
    Gisèle N’kontchou
    Michel Beaugrand
    [J]. World Journal of Gastroenterology, 2007, (17) : 2455 - 2460
  • [3] Vitamin A deficiency in patients with hepatitis C virus-related chronic liver disease
    Peres, W. A. F.
    Chaves, G. V.
    Goncalves, J. C. S.
    Ramalho, A.
    Coelho, H. S. M.
    [J]. BRITISH JOURNAL OF NUTRITION, 2011, 106 (11) : 1724 - 1731
  • [4] Hepatocellular carcinoma in patients with hepatitis C virus-related chronic liver disease
    Trinchet, Jean-Claude
    Ganne-Carrie, Nathalie
    Nahon, Pierre
    N'kontchou, Gisele
    Beaugrand, Michel
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2007, 13 (17) : 2455 - 2460
  • [5] Skin manifestations in patients with hepatitis C virus-related chronic liver disease
    Satta, R.
    Pes, G. M.
    Colosso, B. M. Quarta
    Dore, M. P.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2018, 32 (08) : E305 - E306
  • [6] Transjugular intrahepatic portosystemic shunt for hepatitis C virus-related portal hypertension after liver transplantation
    Ghinolfi, Davide
    De Simone, Paolo
    Catalano, Gabriele
    Petruccelli, Stefania
    Coletti, Laura
    Carrai, Paola
    Marti, Josep
    Tincani, Giovanni
    Cicorelli, Antonio
    Cioni, Roberto
    Filipponi, Franco
    [J]. CLINICAL TRANSPLANTATION, 2012, 26 (05) : 699 - 705
  • [7] Association of tyrosine with insulin resistance in hepatitis C virus-related chronic liver disease
    Yamasaki, Takahiro
    Oono, Takashi
    Zaitsu, Junichi
    Saeki, Issei
    Marumoto, Yoshio
    Hidaka, Isao
    Urata, Yohei
    Ishikawa, Tsuyoshi
    Takami, Taro
    Uchida, Koichi
    Terai, Shuji
    Sakaida, Isao
    [J]. HEPATOLOGY, 2013, 58 : 912A - 912A
  • [8] Association of tyrosine with insulin resistance in hepatitis C virus-related chronic liver disease
    Oono, Takashi
    Yamasaki, Takahiro
    Zaitsu, Junichi
    Saeki, Issei
    Iwamoto, Takuya
    Harima, Yumiko
    Marumoto, Yoshio
    Hidaka, Isao
    Urata, Yohei
    Ishikawa, Tsuyoshi
    Takami, Taro
    Segawa, Makoto
    Uchida, Koichi
    Terai, Shuji
    Kunitugu, Ichiro
    Tanabe, Tsuyoshi
    Sakaida, Isao
    [J]. HEPATOLOGY RESEARCH, 2014, 44 (10) : E54 - E62
  • [9] Efficacy of zinc administration in patients with hepatitis C virus-related chronic liver disease
    Himoto, Takashi
    Hosomi, Naoki
    Nakai, Seiji
    Deguchi, Akihiro
    Kinekawa, Fumihiko
    Matsuki, Michiko
    Yachida, Mikage
    Masaki, Tsutomu
    Kurokochi, Kazutaka
    Watanabe, Seishiro
    Senda, Shoichi
    Kuriyama, Shigeki
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2007, 42 (09) : 1078 - 1087
  • [10] Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease
    Obika, Mikako
    Shinji, Toshiyuki
    Fujioka, Shin-ichi
    Terada, Ryo
    Ryuko, Hiromasa
    Lwin, Aye Aye
    Shiraha, Hidenori
    Koide, Norio
    [J]. INTERVIROLOGY, 2008, 51 (01) : 59 - 68